Par 564 Pill - yellow round
Pill with imprint Par 564 is Yellow, Round and has been identified as Lamotrigine Extended-Release 200 mg. It is supplied by Par Pharmaceutical Inc.
Lamotrigine is used in the treatment of Bipolar Disorder; Lennox-Gastaut Syndrome; Seizure Prevention; Epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Par 564





Lamotrigine Extended-Release
- Imprint
- Par 564
- Strength
- 200 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Triazine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical Inc.
- National Drug Code (NDC)
- 49884-0564
- Inactive Ingredients
-
methacrylic acid,
hypromelloses,
silicon dioxide
Note: Inactive ingredients may vary.
More about lamotrigine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,716)
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: triazine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Lamotrigine drug information
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Orally Disintegrating Tablets
- Lamotrigine Extended-Release Tablets
- Lamotrigine Tablets
Other brands
Lamictal, Lamictal XR, Subvenite, Lamictal ODT, Lamictal CD
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.